Skip to main content Deutsch

Fatty liver

Around 40 percent of the population are already affected by non-alcoholic fatty liver disease.

It can lead to liver inflammation (fatty liver hepatitis), liver cirrhosis and liver cancer. The disease is strongly associated with diabetes, obesity or the metabolic syndrome, but also with genetic processes and changes in the intestinal microbiome.

Currently, no drug therapies have been established for the disease. The main goal in research into non-alcoholic fatty liver is therefore the participation in international clinical study protocols, as well as the characterization of the natural course and non-invasive staging.